Page 4 - Xeraya Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Environmental Impact Acquisition Corporation approval obtained; GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022

/PRNewswire/ Environmental Impact Acquisition Corporation (NASDAQ: ENVI), a publicly-traded special purpose acquisition company, announced today that its.

Canaccord genuityAndrey zarurPurpose acquisition companyContinental grain companySerum life sciencesHannelore grantham environmentalFoley hoagCredit suisseLatham watkinsFund ii spruceEnvironmental impact acquisition corporationCg investments incEnvironmental impact acquisition corpParibas ecosystem restoration fundPura vida investmentsFall line capital

AZ Inno - Phoenix bioscience startup secures $50M to kill cancer using a rabbit virus

AZ Inno - Phoenix bioscience startup secures $50M to kill cancer using a rabbit virus
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaCity hillSteve pottsJoan koerber walkerWidya mulyasasmitaBenjamin rovinskiArizona bioindustry associationBiodesign institute at arizona state universityNational cancer instituteArizona state universityB capital groupBoehringer ingelheim venture fundPhoenix based oncomyx therapeuticsNational cancerPotts oncomyx

OncoMyx closes $50M Series B to advance cancer-killing payload platform

OncoMyx Therapeutics, a privately-held immuno-oncology platform company, today announced the closing of a $50 million Series B financing

United statesSouth koreaCity hillBenjamin beni rovinskiSteve pottsWidya mulyasasmitaB capital groupBoehringer ingelheim venture fundPhoenix based oncomyx therapeuticsLumira venturesDelos capitalXeraya capitalKorea investment partnersCity hill venturesManaging directorSenior principal

P2 Science Launches an Innovative New High-Performance Butter for Cosmetics and Personal Care

Woodbridge, CT (PRWEB) December 06, 2021 P2 Science, Inc.(P2), a green chemistry company, today announced the launch of the first product in the bioderived

United statesNeil burnsPaul anastasBryan chengVp business developmentScience incForest stewardship councilYale centerProfessor paul anastasGreen chemistryXeraya capitalElm street venturesConnecticut innovationsIronwood capitalPress release

Another IPO with Triangle impact: GreenLight Biosciences lands $10M for merger

RESEARCH TRIANGLE PARK - GreenLight Biosciences, which has a growing research and development presence in Research Triangle Park, has announced additional

United statesHudson bayIndia generalNorth carolinaResearch triangle parkAndrey zarurEnvironmental protection agencySerum life sciences ltdContinental grain companySerum life sciencesHannelore grantham environmentalFund ii spruceEnvironmental impact acquisition corpSerum institute of india pvtSerum instituteParibas ecosystem restoration fund